Global Erectile Dysfunction Treatment Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Erectile Dysfunction Treatment Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product (Viagra (sildenafil citrate), Cialis (Tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream), and Other Products), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Erectile Dysfunction Treatment Market was valued at USD 5,093.6 million in 2023 and is expected to reach USD 9,497.9 million by 2031 while growing at a CAGR of 8.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global erectile dysfunction treatment market growth. The goal of erectile dysfunction (ED) treatment is to target the root causes of the condition and enhance erectile function, enabling individuals to attain and sustain satisfactory erections during sexual activity.
The rising prevalence of erectile dysfunction, coupled with advancements in drug delivery technologies like fast-dissolving oral tablets, topical creams, and transdermal patches, fuels the market for erectile dysfunction (ED) treatment. Nevertheless, concerns over adverse effects, safety, and cost constraints act as barriers to the market's growth.
Furthermore, the global erectile dysfunction treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Analysis
The Global Erectile Dysfunction Treatment Market is segmented among Viagra (sildenafil citrate), Cialis (Tadalafil), Levitra/Staxyn (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream), and Other Products, based on Product. In 2023, Viagra (sildenafil citrate) accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Distribution Channel Analysis
The Global Erectile Dysfunction Treatment Market is segmented among Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, based on Distribution Channel. In 2023, Retail Pharmacies accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Erectile Dysfunction Treatment Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Mangoceuticals, Inc, Futura Medical, CURE Pharmaceutical Holding Corp, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc., Boston Scientific, Cipla Ltd, Pfizer Inc., Coloplast CORP, Eli Lily & Co, Gust Inc, Altera, Promedon, Dr. Reddys Laboratories Ltd, Bayer Pharma AG, and Reflexonic LLC.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Erectile Dysfunction Treatment Market Dynamics
Drivers
Restraints
Opportunity
4. Global Erectile Dysfunction Treatment Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5 Global Erectile Dysfunction Treatment Market Segmentation, By Product
Global Erectile Dysfunction Treatment Market Share Analysis, By Product
Global Erectile Dysfunction Treatment Market Growth Analysis, By Product
Global Erectile Dysfunction Treatment Market Trends, By Product
o Viagra (sildenafil citrate)
o Cialis (Tadalafil)
o Levitra/Staxyn (vardenafil)
o Stendra/Spedra (avanafil)
o Zydena (udenafil)
o Vitaros (Alprostadil Cream)
o Other Products
6. Global Erectile Dysfunction Treatment Market Segmentation, By Distribution Channel
Global Erectile Dysfunction Treatment Market Share Analysis, By Distribution Channel
Global Erectile Dysfunction Treatment Market Growth Analysis, By Distribution Channel
Global Erectile Dysfunction Treatment Market Trends, By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
7. Global Erectile Dysfunction Treatment Market Segmentation, By Region
Global Erectile Dysfunction Treatment Market Share Analysis, By Region
Global Erectile Dysfunction Treatment Market Growth Analysis, By Region
Global Erectile Dysfunction Treatment Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Mangoceuticals, Inc*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Futura Medical
CURE Pharmaceutical Holding Corp
Glenmark Pharmaceuticals Ltd
Mylan Pharmaceuticals Inc.
Boston Scientific
Cipla Ltd
Pfizer Inc.
Coloplast CORP
Eli Lily & Co
Gust Inc
Altera
Promedon
Dr. Reddys Laboratories Ltd
Bayer Pharma AG
Reflexonic LLC
*Similar analysis will be provided for each company listed above.